Press Releases

MEDIA CONTACT:
Vincent Lagrotteria, MBA
240-364-6300
info@bridgelaboratories.com
www.bridgelaboratories.com

2008 Releases

October
07

Bridge Laboratories Awarded Major Contract to Support the National Institute on Drug Abuse (NIDA)

September
02

Bridge Laboratories announced today that data from its China lab has been accepted by the FDA.

July
29

Bridge Laboratories Reaches Agreement to Build 2nd Facility in Beijing

January
14

Bridge Laboratories Receives $18 million Financial Backing

2007 Releases

December
15

Bridge Acquires US-based Preclinical Study Company

August
6

Bridge Laboratories' China Facility Receives Full AAALAC Accreditation: First Preclinical CRO with US and China Multispecies Capabilities

February
14

Bridge Announces Closing of its $35 Million Series B Capital Raise to Accelerate its China and US ‘Hybrid’ CRO Model

February
1

Bridge Announces the CRO Industry’s First China-US Visiting Scholar Program for Its Employees

2006 Releases

October
6

Wan Yang Feng, Ph.D. has been appointed Director of Bioanalytic and Metabolism of Bridge Pharmaceutical's Preclinical Laboratory in Beijing

September
6

Bridge Successfully Validates Beijing Preclinical Laboratory

June
12

Bridge Announces $22 Million Series B Capital Raise

June
12

Patrik Sebastian Jeanmonod has been appointed Vice President Finance of Bridge Laboratories, Inc.

June
9

Bridge Laboratories Purchases Provantis Solution for New GLP Laboratory in China

2005 Releases

November
22

San Francisco Business Times: Bridging the biopharmaceutical gap with a new Chinese Lab

November
22

Bridge Laboratories Dedicates Its Preclinical Drug Development Laboratory in Beijing